PCM
GNMK

Penn Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Penn Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-51,858
Closed -$757K – 247
2020
Q4 		$757K Sell
51,858
-212,283
-80% -$2.81M 0.1% 168
2020
Q3 		$3.76M Sell
264,141
-10,545
-4% -$161K 0.48% 91
2020
Q2 		$4.05M Buy
+274,686
New +$2.79M 0.53% 78
2020
Q1 		– Sell
-977,526
Closed -$4.7M – 237
2019
Q4 		$4.7M Buy
977,526
+336,979
+53% +$1.86M 0.49% 75
2019
Q3 		$3.88M Buy
640,547
+2,598
+0.4% +$16.2K 0.4% 96
2019
Q2 		$4.14M Sell
637,949
-33,654
-5% -$237K 0.41% 91
2019
Q1 		$4.76M Sell
671,603
-129,153
-16% -$851K 0.46% 78
2018
Q4 		$3.89M Buy
800,756
+345,692
+76% +$1.8M 0.39% 84
2018
Q3 		$3.35M Sell
455,064
-13
-0% -$95 0.25% 116
2018
Q2 		$2.9M Buy
455,077
+33,644
+8% +$222K 0.22% 128
2018
Q1 		$2.29M Sell
421,433
-122,282
-22% -$608K 0.18% 149
2017
Q4 		$2.27M Buy
543,715
+196,150
+56% +$1.18M 0.16% 159
2017
Q3 		$3.35M Buy
+347,565
New +$3.61M 0.24% 122

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Penn Capital Management's GNMK Position: Q1 2021 in Review

Penn Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 51,858 shares — an estimated $757K sold.

Penn Capital Management first reported a position in GNMK in Q3 2017 and held it in 13 quarters. The position peaked at $4.76M in Q1 2019. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Penn Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Penn Capital Management sold 51,858 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $757K.
  • Penn Capital Management first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 13 quarters.
  • Penn Capital Management's GenMark Diagnostics, Inc position peaked at $4.76M in Q1 2019.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Penn Capital Management's 13F filing for Q1 2021, filed 13 May 2021.